CAS 1044758-60-2

Etrolizumab

CAS: 1044758-60-2

MEDI-578 is a CHO-expressed humanized monoclonal antibody targeting NGF/bNGF for the study of neurological and immune system disorders.

Pureza: 98.9% (SDS-PAGE); 96.6% (SEC-HPLC) - 98.9% (SDS-PAGE); 96.6% (SEC-HPLC)

Cor e Forma: Liquid

Peso molecular: 144.1 kDa

Ref: TM-T77154

Etrolizumab

CAS: 1044758-60-2

Anti-Human α4β7 Monoclonal Antibody

Ref: 3D-CLA1265